Leading United Arab Emirates lawyer Essam al-Tamimi has welcomed thegovernment's approval of a draft patent law with a view to encouraging foreign and local drugmakers to develop and invest in the local market. The law is expected to take effect in 2000.
Mr Tamimi said the UAE had been given until 2005 to comply with World Trade Organization requirements, but had no reason to delay. Saudi Arabia introduced patent protection for drugs in 1989 and local generic firms were licensed by international companies to produce drugs. The multinationals were not opposing the local manufacture and sale of drugs, he said, but wanted to draw the local authorities' attention to develop the UAE and Dubai in particular as an international center for the Middle East.
Local firms are producing unauthorized drugs which are patented and recognized as owned and registered by international companies under international names, he said, but: "unauthorized production and sale of pharmaceutical products in the UAE will never win, and will discourage technology and capital transfer." While local firms could obtain a licence to produce drugs under certain terms, "they chose the easy and unethical way" of doing this.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze